REFERENCES
- Guillemin, R. and Schally, A. V.: Recent advances in the chemistry of neuroendocrine mediators originating in the central nervous system. In Nalbandov, A. V. (Editor): Advances in Neuro-endocrinology. Urbana, Illinois, University of Illinois Press, 1963, chap. 10, pp. 314–328.
- Nelson, A. A. and Woodard, G.: Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(parachloro-phenyl)-l,l-dichloroethane (DDD or TDE). Arch. Path. 48: 387, 1949.
- Chart, J. J., Sheppard, H., Mowles, T. and Howie, N.: Inhibitors of adrenal corticosteroid 17α-hydroxylation. Endocrinology 71: 479, 1962.
- Chart, J. J., Sheppard, H., Allen, M. J., Bencze, W. L. and Gaunt, R.: New amphenone analogs as adrenocortical inhibitors. Experientia 14: 151, 1958.
- Dominguez, O. V. and Samuels, L. T.: Mechanism of inhibition of adrenal steroid 11β-hydroxylase by methopyrapone (Metopirone). Endocrinology 73: 304, 1963.
- Gaunt, R., Chart, J. J. and Renzi, A. A.: Interactions of drugs with endocrines. Ann. Rev. Pharmacol. 3: 109–128, 1963.
- Neher, R.: Discussion of paper by J. J. Chart. Proceedings of the First International Congress on Hormonal Steroids, Milan. (In press.)
- Cleveland, W. W., Nikezic, M. and Migeon, C. J.: Response to an 11β-hydroxylase inhibitor (Su-4885) in males with adrenal hyperplasia and in their parents. J. Clin. Endocrinol. 22: 281, 1962.
- Hudson, B. and Evans, J.: Adrenocortical hyperplasia associated with bronchogenic carcinoma. J. Clin. Endocrinol. 22: 494, 1962.